These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 2566200)

  • 41. Stress ulcer prophylaxis in patients on ventilator.
    Darlong V; Jayalakhsmi TS; Kaul HL; Tandon R
    Trop Gastroenterol; 2003; 24(3):124-8. PubMed ID: 14978984
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pathophysiology and prophylaxis of stress ulcer in intensive care unit patients.
    Stollman N; Metz DC
    J Crit Care; 2005 Mar; 20(1):35-45. PubMed ID: 16015515
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Gastroduodenal stress lesions and hemorrhages--pathogenesis, diagnosis, prevention and therapy].
    Gheorghiu T
    Zentralbl Chir; 1995; 120(9):670-6. PubMed ID: 7483866
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacological interventions for stress ulcer prophylaxis in critically ill patients: a mixed treatment comparison network meta-analysis and a recursive cumulative meta-analysis.
    Sridharan K; Sivaramakrishnan G; Gnanaraj J
    Expert Opin Pharmacother; 2018 Feb; 19(2):151-158. PubMed ID: 29271262
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prevention of stress ulcer with topically acting drugs: an effective and sensible therapeutic approach? Arguments contra].
    Janisch HD
    Z Gastroenterol; 1991 Jan; 29 Suppl 1():19-20; discussion 21-2. PubMed ID: 1962496
    [No Abstract]   [Full Text] [Related]  

  • 46. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. Canadian Critical Care Trials Group.
    Cook D; Guyatt G; Marshall J; Leasa D; Fuller H; Hall R; Peters S; Rutledge F; Griffith L; McLellan A; Wood G; Kirby A
    N Engl J Med; 1998 Mar; 338(12):791-7. PubMed ID: 9504939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Current concepts in clinical therapeutics: peptic ulcer disease.
    Siepler JK; Mahakian K; Trudeau WT
    Clin Pharm; 1986 Feb; 5(2):128-42. PubMed ID: 2869852
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changing perspectives of H2 antagonists for stress ulcer prophylaxis.
    Bezarro ER
    Crit Care Nurs Clin North Am; 1993 Jun; 5(2):325-31. PubMed ID: 8104424
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis. ASHP Commission on Therapeutics and approved by the ASHP Board of Directors on November 14, 1998.
    Am J Health Syst Pharm; 1999 Feb; 56(4):347-79. PubMed ID: 10690219
    [No Abstract]   [Full Text] [Related]  

  • 50. Prophylaxis against acute stress erosions.
    Luk GD
    South Med J; 1980 Apr; 73(4):424-6. PubMed ID: 7367930
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of histamine H2 receptor antagonists in nonoperative management of gastroduodenal ulcer haemorrhage.
    Haglund U
    Scand J Gastroenterol Suppl; 1987; 137():39-42. PubMed ID: 2892262
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prevention of stress-induced hemorrhage of the upper gastrointestinal tract].
    Simon B; Müller P; Kather H
    MMW Munch Med Wochenschr; 1981 Jun; 123(23):955-6. PubMed ID: 6114423
    [No Abstract]   [Full Text] [Related]  

  • 53. [Prevention of stress-induced lesions of the gastrointestinal mucosa by means of drugs].
    Ditschuneit H; Malfertheiner P
    Med Welt; 1982 Jan; 33(1):78-82. PubMed ID: 6120435
    [No Abstract]   [Full Text] [Related]  

  • 54. Stress ulcer prophylaxis in critically ill patients.
    Lancet; 1989 Nov; 2(8674):1255-6. PubMed ID: 2573766
    [No Abstract]   [Full Text] [Related]  

  • 55. Update on stress ulcer prophylaxis in critically ill patients.
    Spirt MJ; Stanley S
    Crit Care Nurse; 2006 Feb; 26(1):18-20, 22-8; quiz 29. PubMed ID: 16443807
    [No Abstract]   [Full Text] [Related]  

  • 56. Prospective endoscopic study of stress erosions and ulcers in critically ill neurosurgical patients: current incidence and effect of acid-reducing prophylaxis.
    Reusser P; Gyr K; Scheidegger D; Buchmann B; Buser M; Zimmerli W
    Crit Care Med; 1990 Mar; 18(3):270-4. PubMed ID: 2302950
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The clinical problem of stress ulcers.
    Silen W
    Clin Invest Med; 1987 May; 10(3):270-4. PubMed ID: 2887324
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Intravenous gastric acid inhibition for stress ulcers and bleeding peptic ulcers].
    Geus WP; Lamers CB
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2514-8. PubMed ID: 10627753
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Continuous intravenous cimetidine decreases stress-related upper gastrointestinal hemorrhage without promoting pneumonia.
    Martin LF; Booth FV; Karlstadt RG; Silverstein JH; Jacobs DM; Hampsey J; Bowman SC; D'Ambrosio CA; Rockhold FW
    Crit Care Med; 1993 Jan; 21(1):19-30. PubMed ID: 8420726
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stress ulcer prophylaxis in the postoperative period.
    Allen ME; Kopp BJ; Erstad BL
    Am J Health Syst Pharm; 2004 Mar; 61(6):588-96. PubMed ID: 15061430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.